FGFR4 is a driver of some solid tumors, for example, rhabdomyosarcoma (RMS) and hepatocellular carcinoma (HCC), and hence has attracted efforts to seek highly selective inhibitors.82 The gene discussed is FGFR4; the disease is hepatocellular carcinoma.